These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 717937)

  • 1. Granulomatous hepatitis: a hypersensitivity response to procainamide.
    Rotmensch HH; Yust I; Siegman-Igra Y; Liron M; Ilie B; Vardinon N
    Ann Intern Med; 1978 Nov; 89(5 Pt 1):646-7. PubMed ID: 717937
    [No Abstract]   [Full Text] [Related]  

  • 2. Fever, vomiting, and liver dysfunction with procainamide therapy.
    Farber HI
    Postgrad Med; 1974 Jul; 56(1):155-6. PubMed ID: 4835003
    [No Abstract]   [Full Text] [Related]  

  • 3. Granulomatous hepatitis as a manifestation of quinidine hypersensitivity.
    Bramlet DA; Posalaky Z; Olson R
    Arch Intern Med; 1980 Mar; 140(3):395-7. PubMed ID: 7362358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmia prophylaxis with procaine amide: plasma concentrations in relation to dose.
    Collste P; Karlsson E
    Acta Med Scand; 1973 Nov; 194(5):405-11. PubMed ID: 4757219
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypersensitivity reaction associated with acute hepatic dysfunction following a single intravenous dose of procainamide.
    Worman HJ; Ip JH; Winters SL; Tepper DC; Gomes AJ
    J Intern Med; 1992 Oct; 232(4):361-3. PubMed ID: 1402640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexplained fever and chills associated with myocardial infarction.
    el Shahawy M; Flowers NC
    Chest; 1972 Sep; 62(3):263-5. PubMed ID: 5056585
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction.
    Koch-Weser J; Klein SW; Foo-Canto LL; Kastor JA; DeSanctis RW
    N Engl J Med; 1969 Dec; 281(23):1253-60. PubMed ID: 4900236
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma levels of procaine amide after administration of conventional and sustained-release tablets.
    Karlsson E
    Eur J Clin Pharmacol; 1973 Dec; 6(4):245-50. PubMed ID: 4591151
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term use of procaine amide following acute myocardial infarction.
    Kosowsky BD; Taylor J; Lown B; Ritchie RF
    Circulation; 1973 Jun; 47(6):1204-10. PubMed ID: 4122729
    [No Abstract]   [Full Text] [Related]  

  • 10. Pure red cell aplasia associated with administration of sustained-release procainamide.
    Giannone L; Kugler JW; Krantz SB
    Arch Intern Med; 1987 Jun; 147(6):1179-80. PubMed ID: 3036033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procainamide in plasma following administration of sustained-release tablets in acute myocardial infarction.
    Ihlen H; Skomedal T; Stafsnes H; Ditlefsen EM
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):257-62. PubMed ID: 805020
    [No Abstract]   [Full Text] [Related]  

  • 12. Febrile reactions to procainamide.
    Knight PO; Baumann DP
    JFMA; 1972 Apr; 59(4):34. PubMed ID: 5033037
    [No Abstract]   [Full Text] [Related]  

  • 13. Agranulocytosis due to new sustained-release procainamide.
    Berger BE; Hauser DJ
    Am Heart J; 1983 Jun; 105(6):1035-6. PubMed ID: 6858823
    [No Abstract]   [Full Text] [Related]  

  • 14. Intrahepatic cholestasis due to hypersensitivity reaction to procainamide.
    Ahn CS; Tow DE
    Arch Intern Med; 1990 Dec; 150(12):2589-90. PubMed ID: 2244779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procainamide in acute myocardial infarction: a study on two different tablet preparations of sustained release type.
    Ihlen H; Ditlefsen L
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):720-6. PubMed ID: 812650
    [No Abstract]   [Full Text] [Related]  

  • 16. Possible case of procainamide-induced intrahepatic cholestatic jaundice.
    Chuang LC; Tunier AP; Akhtar N; Levine SM
    Ann Pharmacother; 1993 Apr; 27(4):434-7. PubMed ID: 8477118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral administration of procainamide for ventricular arrhythmia. Plasma concentrations during use of tablets(Pronestyl) and a slow-release preparation (Porcainamide Durettes)].
    Bliddal J
    Ugeskr Laeger; 1976 Sep; 138(40):2425-33. PubMed ID: 968996
    [No Abstract]   [Full Text] [Related]  

  • 18. Diltiazem-induced granulomatous hepatitis.
    Toft E; Vyberg M; Therkelsen K
    Histopathology; 1991 May; 18(5):474-5. PubMed ID: 1885169
    [No Abstract]   [Full Text] [Related]  

  • 19. Control of procainamide therapy after cardiac infarction.
    Royds R; Shaw TR; Kumana CR; Padgham D; Hamer J
    Br Heart J; 1973 Aug; 35(8):862-3. PubMed ID: 4729848
    [No Abstract]   [Full Text] [Related]  

  • 20. Quinidine hypersensitivity and liver involvement. A survey of 32 patients.
    Geltner D; Chajek T; Rubinger D; Levij IS
    Gastroenterology; 1976 May; 70(5 PT.1):650-2. PubMed ID: 1261756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.